Sanco Industries fixes June 5 record date for share issuance

Sanco Industries Limited has fixed Friday, June 5, 2026, as the record date to determine the eligibility of stakeholders for the issuance and allotment of equity shares. The Board of Directors approved this date during its meeting held on Thursday, May 20, 2026. The issuance is being carried out pursuant to the Resolution Plan approved by the Hon'ble NCLT, New Delhi Bench, vide order dated December 18, 2025.

Background of the Resolution Plan

The company underwent the Corporate Insolvency Resolution Process (CIRP) following an order by the Hon'ble NCLT dated September 29, 2022. The Resolution Plan submitted by Ms. Priti Jain was approved by the Committee of Creditors (CoC) with 100% voting share in its meeting held on April 28, 2023. Subsequently, the NCLT approved the plan on December 18, 2025.

Corporate Structure Changes

Pursuant to the approved Resolution Plan, Sanco Industries Limited (Transferor Company) stands amalgamated with Sanco Industries Limited, formerly known as Carewell Exim Private Limited (Transferee Company). The Transferee Company has since converted into a public limited company. Following a fresh Certificate of Incorporation dated May 14, 2026, the name of the Transferee Company was changed to Sanco Industries Limited.

Record Date Details

The following table outlines the key details regarding the record date:

S. No Particulars Details 1. Purpose Issuance and allotment of equity share pursuant to approved Resolution Plan 2. Record date Friday, June 5, 2026

Sanco Industries Limited has submitted a regulatory disclosure to NSE confirming its non-applicability under SEBI's Large Corporate framework and providing updates on the completion of its Corporate Insolvency Resolution Process (CIRP). The disclosure, dated April 24, 2026, addresses multiple regulatory requirements and corporate restructuring developments.

SEBI Large Corporate Classification Status

The company has formally confirmed that it does not qualify as a Large Corporate under SEBI's debt securities fund raising framework. According to SEBI circulars dated November 26, 2018, August 10, 2021, and October 19, 2023, entities must meet specific criteria to be classified as Large Corporates.

Criteria: Requirement Sanco Industries Status Outstanding Long-term Borrowings: ₹1,000 crore or above Does not meet Credit Rating: AA and above Does not meet Listed Status: Specified securities listed Does not meet

Since Sanco Industries Limited fails to satisfy these criteria, the disclosure requirements applicable to Large Corporates under the SEBI framework are not applicable to the company.

Corporate Insolvency Resolution Process Completion

The company has successfully completed its Corporate Insolvency Resolution Process, which commenced following an NCLT order dated September 29, 2022. The resolution plan submitted by Ms. Priti Jain received unanimous approval from the Committee of Creditors with 100% voting in their 12th meeting held on April 28, 2023. The Hon'ble NCLT subsequently approved this resolution plan through its order dated December 18, 2025.

Corporate Restructuring and Amalgamation

Under clause 4.1.3 of the approved Resolution Plan and applicable provisions of the Insolvency and Bankruptcy Code, 2016, Sanco Industries Limited has been amalgamated with Carewell Exim Private Limited. The restructuring involves several key steps:

Process Step: Details Amalgamation: Sanco Industries Limited merged with Carewell Exim Private Limited Conversion Process: Transferee company converting to public limited status Name Change: Carewell Exim to adopt "Sanco Industries Limited" name Regulatory Filings: Applications submitted to concerned authorities

Future Listing and Compliance Framework

According to clause 4.1.5 of the approved Resolution Plan, the transferee company will become an active listed entity upon completion of all statutory, regulatory, and listing formalities. The equity shares will be listed and traded under the name "Sanco Industries Limited" with NSE symbol "SANCO", subject to approvals from relevant regulatory authorities including stock exchanges.

All future listing compliances, disclosures, and regulatory requirements for Sanco Industries Limited will be undertaken based on the financials, records, and data of the transferee company, Carewell Exim Private Limited.

Regulatory Compliance

The disclosure was signed by Pankaj Saxena, Additional Director (DIN: 08162590), on April 24, 2026, from Delhi. This communication ensures compliance with applicable disclosure requirements and provides transparency regarding the company's current status under various regulatory frameworks.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.